Institute of Molecular and Translational Medicine

Institute of Molecular and Translational Medicine Kontaktní informace, mapa a trasa, kontaktní formulář, otevírací doba, služby, hodnocení, fotky, videa a oznámení od Institute of Molecular and Translational Medicine, Centrum pro lékařský výzkum, Hněvotínská 1333/5, Olomouc.

The Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University in Olomouc is cutting-edge biomedical research institute in the Czech Republic.

Marián Hajdúch explains how a potential cancer drug is developed, from an initial laboratory compound to an approved med...
03/02/2026

Marián Hajdúch explains how a potential cancer drug is developed, from an initial laboratory compound to an approved medicine. It outlines the key stages of the process, including basic research, preclinical testing, and multi-phase clinical trials in patients. 🔬

Watch the whole interview 👉 www.ceskatelevize.cz/porady/1096902795-studio-6/226411010100203/cast/1166895/

The segment also highlights how long and demanding drug development is, the importance of safety and efficacy testing, and the role of regulatory authorities before a drug can be used in clinical practice. ✅

According to doctors, dozens of cancer cases are missed every year because standard Pap smear tests fail to detect up to...
20/01/2026

According to doctors, dozens of cancer cases are missed every year because standard Pap smear tests fail to detect up to 30% of tumors. These tests often catch only later cell changes, not the root cause: HPV infection. ❗️

“HPV DNA tests are much more sensitive and detect cancer risk in over 95% of cases,” says Marián Hajdúch, Medical Director of the National Institute for Cancer Research NÚVR - Národní ústav pro výzkum rakoviny . “They can identify the disease much earlier, before cells start to change.”

Despite this, insurance currently covers HPV DNA testing only three times in a woman’s life. Many European countries already offer regular HPV testing from age 25. Why is the Czech system lagging behind? Read more in the article 👇👇👇

Změňme způsob, jakým u žen hledáme rakovinu děložního čípku. Je nevhodně nastavený, tvrdí lékař a vědec Marián Hajdúch.

We are pleased to highlight the 4th Congress of Airway Diagnostics and Intervention (DIDC 2025), held with the support o...
19/01/2026

We are pleased to highlight the 4th Congress of Airway Diagnostics and Intervention (DIDC 2025), held with the support of EATRIS Czech Republic and featured within the EATRIS Spotlight Programme. 💫

DIDC 2025 took place on December 1–2, 2025, in Prague and served as an important platform connecting clinical practice, preventive approaches, and translational research in respiratory medicine. The congress brought together Czech and international expertise, with a strong focus on multi-omics, digital health, and personalised medicine within the EATRIS-CZ network.
More info ➡ www.plicnikongres.cz

Eatris

NICR & EATRIS-CZ: Platform for accelerating biomedical innovations 💫The major research infrastructure EATRIS connects mo...
16/12/2025

NICR & EATRIS-CZ: Platform for accelerating biomedical innovations 💫

The major research infrastructure EATRIS connects more than 120 research institutions and 11 Czech centers, including NUVR. Together, we build an infrastructure that accelerates the translation of basic research results into clinical practice.

✅ Helps transfer basic research findings into clinical applications.
✅ Contributes to the development of new drugs and diagnostic tools.
✅ Connects experts across Europe – from molecule design to patient testing.

Watch how the collaboration between Eatris and NÚVR - Národní ústav pro výzkum rakoviny is transforming medicine across Europe.

💡 EATRIS-CZ. Evropská síť mozků i technologií. 👉 Velká výzkumná infrastruktura EATRIS propojuje více než 120 výzkumných institucí a 11 českých center včet...

15/12/2025

💡 NICR: WHY WAS A NETWORK THAT IS TRANSFORMING CANCER RESEARCH CREATED?

🔬 Biomedical research is not just about cells — it is about the people who search for answers among them.
NICR is a network that connects the laboratory, the clinic, and society, changing the way cancer research is developed in the Czech Republic.
In the Mezi buňky podcast, the three NÚVR - Národní ústav pro výzkum rakoviny (NICR) directors explain how this collaboration came about and what it means for patients and for the future of Czech science.

08/12/2025

CACR 2025: KEY HIGHLIGHTS AND RESULTS OF THE NÚVR PROJECT ✨

📊 This year’s CACR Meeting—the largest national oncology conference in the Czech Republic—offered not only a top-tier scientific program, but also a major presentation of the NÚVR project results and a discussion on its future direction during the sustainability phase.

➡️ You can see what it was like in the video.

Thrilled to be in the Spotlight! 🌟🎄🎁On behalf of the Czech node, many thanks to our Portuguese colleagues for the inspir...
05/12/2025

Thrilled to be in the Spotlight! 🌟🎄🎁

On behalf of the Czech node, many thanks to our Portuguese colleagues for the inspiring handover in Lisbon and to the entire community for the trust and support.

We look forward to working with all of you on turning precision and personalised health innovations into real benefits for patients – from cutting-edge multiomics and advanced imaging to clinical translation, AI and digital health.

🇨🇿 Let’s make the Spotlight a driver of new collaborations, joint projects and better care across Europe.

🇨🇿 Spotlight on the Czech Republic! Following the handover from Portugal this week in Lisbon, the Czech Republic has now officially stepped into the EATRIS Spotlight programme, with the topic “Precision and Personalised Health – from Discovery to Patient.”

The Czech Spotlight Programme highlights the country’s contribution to building a future where healthcare is more precise, predictive, and patient-centred. The programme will showcase pioneering projects, infrastructures, and partnerships that embody this vision – from biomarker-driven cancer therapies to AI-powered digital twins for healthy ageing.

👉 Find out more here: https://eatris.eu/countries/czech-republic/

From 24 to 26 November 2025, more than 300 leading figures from Czech and international scientific and biomedical commun...
04/12/2025

From 24 to 26 November 2025, more than 300 leading figures from Czech and international scientific and biomedical communities gathered in Olomouc for the Czech Annual Cancer Research Meeting (CACR Meeting 2025). This year, the meeting proudly marked its 20th anniversary! 💫👏

This year’s CACR Meeting featured nearly 50 oral presentations and more than 90 posters. Conference President and NICR Medical Director Marián Hajdúch reminded attendees that scientific meetings dedicated to cancer research have a twenty-year tradition in Olomouc. Over the past four years, the gathering has been co-organized under the CACR Meeting brand together with NICR, MedChemBio and the national research infrastructure for translational medicine, EATRIS-CZ.

NÚVR - Národní ústav pro výzkum rakoviny (NICR) also presented the results of its 3.5 years of existence. In his opening remarks, NICR Director Aleksi Šedo emphasized that the establishment of NICR as a distributed network—uniting 11 academic institutions and 71 of their top research teams across three hubs (Prague, Brno, and Olomouc) through the National Recovery Plan’s EXCELES program. 🔬

Full article with photogallery ➡ https://imtm.cz/news/cacr-2025-fundamental-cancer-research-patients-bedside

📷 Denisa Pavelková

Eatris

When science in the Czech republic joins forces 💪Today’s Review Conference of the EXCELES projects brought together memb...
03/12/2025

When science in the Czech republic joins forces 💪

Today’s Review Conference of the EXCELES projects brought together members and representatives of participating projects and institutions in Prague to jointly assess their results and outline possible directions for the next phase of collaboration.

Under the auspices of the Mayor of Prague, doc. MUDr. Bohuslav Svoboda, CSc., the conference opened with presentations by the directors of the EXCELES programs:
prof. MUDr. Aleksi Šedo, DrSc., Director of NÚVR - Národní ústav pro výzkum rakoviny
RNDr. PhDr. Zdeněk Hostomský, CSc., Director of NIVB
prof. MUDr. Robert Jech, Ph.D., Deputy Scientific Director of NEUR-IN
prof. Mgr. Klára Šeďová, Ph.D., Director of SYRI

Alžběta Srovnalová presented her work at the CytoData 2025 conference in Berlin 💫Our colleague Alžběta Srovnalová presen...
25/11/2025

Alžběta Srovnalová presented her work at the CytoData 2025 conference in Berlin 💫

Our colleague Alžběta Srovnalová presented her poster titled “High Content Morphology Profiling Enables Discovery Of Autophagy-Modulating Therapeutics” at the CytoData 2025 conference in Berlin.

The event was held at the Campus Berlin-Buch on 20–21 November 2025 and brought together experts in image-based profiling, high-content screening, and data-driven cell biology. Congratulations! 👏

📣 Join NICR Edu Lectures at the Czech Annual Cancer Research Meeting 2025! Don’t miss this inspiring session full of ins...
20/11/2025

📣 Join NICR Edu Lectures at the Czech Annual Cancer Research Meeting 2025! Don’t miss this inspiring session full of insights, challenges, and amazing presentations.

REGISTRATION ➡ https://cancermeeting.cz/nicr-edu-workshop/

NÚVR - Národní ústav pro výzkum rakoviny

💊 Join NICR Edu Lectures at the Czech Annual Cancer Research Meeting 2025! Some of you are already doing a great job pop...
18/11/2025

💊 Join NICR Edu Lectures at the Czech Annual Cancer Research Meeting 2025! Some of you are already doing a great job popularizing your research, while others may still be hesitating. But NICR Edu at the CACR Meeting 2025 is here for everyone!

➡️ https://cancermeeting.cz/nicr-edu-workshop/

💬 In an open and fair environment, you’ll learn how to communicate science clearly and with respect.
💡 Get inspired, share your experiences, and take your science communication to the next level.
🧠 And most importantly — you’ll get to try everything out in practice during individual workshops!

📍 Don’t miss this inspiring session full of insights, challenges, and success stories!

Adresa

Hněvotínská 1333/5
Olomouc
77900

Telefon

+420585632111

Internetová stránka

Upozornění

Buďte informováni jako první, zašleme vám e-mail, když Institute of Molecular and Translational Medicine zveřejní novinky a akce. Vaše emailová adresa nebude použita pro žádný jiný účel a kdykoliv se můžete odhlásit.

Kontaktujte Praxe

Pošlete zprávu Institute of Molecular and Translational Medicine:

Sdílet

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

IMTMnstitute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University Olomouc

Our mission is to perform basic and translational biomedical research with an aim to better understand the underlying cause of human infectious diseases and cancer, and to develop future human medicines, medical devices and diagnostics. Our vision is to facilitate private-public partnership and research collaboration, and to integrate member researchers into international platforms. We aim to further strengthen IMTM as a premier educational center and provide quality education in biomedical science at the bachelor's, master's and doctoral levels. In order to accomplish these goals, IMTM brings and maintains 'under one roof' two types of infrastructures for basic and translational biomedical research.


  • High-quality physical resources, such as state-of-the-art imaging facilities, high throughput screening and omics technologies, high-quality animal facilities, clinical centers, biobank, etc.

  • Scientific and highly professional project management team to guide translational research projects, and to educate and train students, young scientists and research-oriented clinicians.